Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Implications of altered NAD metabolism in metabolic disorders

Open access
Okabe, Keisuke, Yaku, Keisuke, Tobe, Kazuyuki, Nakagawa, Takashi · 2019 · Journal of Biomedical Science

Abstract

Nicotinamide adenine dinucleotide (NAD) is an important coenzyme that participates in various energy metabolism pathways, including glycolysis, β-oxidation, and oxidative phosphorylation. Besides, it is a required cofactor for post-translational modifications such as ADP-ribosylation and deacetylation by poly (ADP-ribose) polymerases (PARPs) and sirtuins, respectively. Thus, NAD regulates energy metabolism, DNA damage repair, gene expression, and stress response through these enzymes. Numerous studies have shown that NAD levels decrease with aging and under disturbed nutrient conditions, such as obesity. Additionally, a decline in NAD levels is closely related to the development of various metabolic disorders, including diabetes and fatty liver disease. In addition, many studies have revealed that administration of NAD precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), efficiently increase NAD levels in various tissues and prevent such metabolic diseases. These NAD precursors are contained in natural foods, such as cow milk, vegetables, and meats. Therefore, altered NAD metabolism can be a practical target for nutritional intervention. Recently, several human clinical trials using NAD precursors have been conducted to investigate the safety, pharmacokinetics, and efficacy against metabolic disorders such as glucose intolerance. In this review, we summarize current knowledge on the implications of NAD metabolism in metabolic diseases and discuss the outcomes of recent human clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12929-019-0527-8

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 NAD metabolism has a potential protective effect against various metabolic diseases through redox reactions, sirtuins, and possibly PARPs. NAD is a co-enzyme that mediates various redox reactions in glycolysis, the TCA cycle, fatty acid oxidation, and oxidative phosphorylation. It also serves as a substrate for PARPs and sirtuins and regulates various biological pathways, including energy metabolism, gene expression, DNA repair, and cellular stress response
Fig. 1 NAD metabolism has a potential protective effect against various metabolic diseases through redox reactions, sirtuins, and possibly PARPs. NAD is a co-enzyme that mediates various redox reactions in glycolysis, the TCA cycle, fatty acid oxidation, and oxidative phosphorylation. It also serves as a substrate for PARPs and sirtuins and regulates various biological pathways, including energy metabolism, gene expression, DNA repair, and cellular stress responseCC BY · PubMed Central
Fig. 2 NAD is synthesized through de novo, Preiss-Handler, and salvage pathways. NAM: nicotinamide, NA; nicotinic acid, NAD: nicotinamide adenine dinucleotide, NMN: nicotinamide mononucleotide, NR: nicotinamide riboside, NAAD: nicotinic acid adenine dinucleotide, Nampt: nicotinamide phophoribosyltransferase, Nmnat: NMN adenylyltransferase, NADS: NAD synthase, NRK: nicotinamide riboside kinase
Fig. 2 NAD is synthesized through de novo, Preiss-Handler, and salvage pathways. NAM: nicotinamide, NA; nicotinic acid, NAD: nicotinamide adenine dinucleotide, NMN: nicotinamide mononucleotide, NR: nicotinamide riboside, NAAD: nicotinic acid adenine dinucleotide, Nampt: nicotinamide phophoribosyltransferase, Nmnat: NMN adenylyltransferase, NADS: NAD synthase, NRK: nicotinamide riboside kinaseCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 109 references

Cited by

See all 223

Metadata

Authors
Okabe, K., Yaku, K., Tobe, K., & Nakagawa, T.
Affiliations
University of Toyama (JP)
Corresponding author
Nakagawa, Takashi
Venue
Journal of Biomedical Science
Published
2019-05-11
Volume
26
Issue
1
Pages
34-34
ISSN
  • 1021-7770 (ISSN-L)
  • 1423-0127
OpenAlex
W2944227504
Cited by
223
References
109
Citations by year
2026: 17 · 2025: 34 · 2024: 28 · 2023: 28 · 2022: 41 · 2021: 40 · 2020: 32 · 2019: 3
FWCI
3.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biomedical Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Japan Society for the Promotion of Science (17K08653, 18K17921, 18K16193)
  • Takeda Science Foundation
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
NAD+ metabolism, metabolic disorders, nicotinamide mononucleotide, nicotinamide riboside, NAD+ precursors, poly(ADP-ribose) polymerase, sirtuins, ADP-ribosylation, ADP-ribosyltransferase, aging, obesity, diabetes mellitus, hepatic steatosis, impaired glucose tolerance, dietary intervention
MeSH terms
Diet, Humans, Metabolic Diseases, NAD

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implications of altered NAD metabolism in metabolic disorders. https://app.cochat.ai/papers/10.1186/s12929-019-0527-8
The paper
Okabe, K., Yaku, K., Tobe, K., & Nakagawa, T. (2019). Implications of altered NAD metabolism in metabolic disorders. Journal of Biomedical Science. https://doi.org/10.1186/s12929-019-0527-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.